The value of dehydroepiandrosterone sulfate measurement in the differentiation between benign and malignant adrenal masses

被引:30
作者
Terzolo, M [1 ]
Ali, A [1 ]
Osella, G [1 ]
Reimondo, G [1 ]
Pia, A [1 ]
Peretti, P [1 ]
Paccotti, P [1 ]
Angeli, A [1 ]
机构
[1] Univ Toronto, Azienda Osped San Luigi, Med Clin, Dipartimento Sci Clin & Biol, I-10043 Orbassano, TO, Italy
关键词
D O I
10.1530/eje.0.1420611
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: Owing to their increasing rate of discovery as incidental findings, the characterization of adrenal masses is an important diagnostic problem which frequently challenges the clinician's skill. Design: The results of dehydroepiandrosterone sulfate (DHEAS) measurement were evaluated in a consecutive series of 107 patients with an adrenal mass (39 men, 68 women aged 15-81 years, median 56 years). DHEAS levels observed in the patients were categorized as reduced, normal or elevated according to sex- and age-adjusted reference ranges obtained by measuring DHEAS in 214 healthy women and 142 healthy men aged 17-93 years. The working hypothesis was that a low DHEAS level is a marker of benignity. Methods: In 84 patients. the adrenal mass was discovered serendipitously, while in the remainder the mass was clinically symptomatic. Patients with known extra-adrenal malignancies were excluded. The adrenal masses were categorized as benign or malignant by computerized tomography (CT) criteria. All patients with suspected malignant tumors or with overtly hypersecreting tumors underwent adrenalectomy. The patients with a presumptive benign tumor were followed-up for at least 12 months. Results: In the overall series, the sensitivity and specificity of a low DHEAS level in the identification of a benign lesion were 41% and 100% respectively. Superimposable figures were obtained when considering only adrenal incidentalomas. DHEAS levels in adrenal cancers displayed some overlap with adrenal adenomas, but in only 2/11 adrenal cancers were DHEAS levels normal, while they were elevated in the remainder. Conclusions: The present data suggest that DHEAS measurement may help to differentiate benign from malignant adrenal masses as a complementary test of CT in a clinical research setting. The value of DHEAS measurement in general practice is limited because it may be difficult to differentiate between low and low-normal values, particularly in the elderly.
引用
收藏
页码:611 / 617
页数:7
相关论文
共 24 条
[1]   ABNORMALITIES OF ENDOCRINE FUNCTION IN PATIENTS WITH CLINICALLY SILENT ADRENAL MASSES [J].
AMBROSI, B ;
PEVERELLI, S ;
PASSINI, E ;
RE, T ;
FERRARIO, R ;
COLOMBO, P ;
SARTORIO, A ;
FAGLIA, G .
EUROPEAN JOURNAL OF ENDOCRINOLOGY, 1995, 132 (04) :422-428
[2]   Incidentally discovered adrenal tumors: Endocrine scintigraphic correlates [J].
Barzon, L ;
Scaroni, C ;
Sonino, N ;
Fallo, F ;
Gregianin, M ;
Macri, C ;
Boscaro, M .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1998, 83 (01) :55-62
[3]   Low dehydroepiandrosterone sulfate (DHEA-S) level is not a good predictor of hormonal activity in nonselected patients with incidentally detected adrenal tumors [J].
Bencsik, Z ;
Szabolcs, I ;
Kovacs, Z ;
Ferencz, A ;
Voros, A ;
Kaszas, I ;
Bor, K ;
Gonczi, J ;
Goth, M ;
Kovacs, L ;
Dohan, O ;
Szilagyi, G .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1996, 81 (05) :1726-1729
[4]   Utility of plasma dehydroepiandrosterone sulphate determination in adrenal incidentalomas [J].
Bernini, GP ;
Argenio, GF ;
Vivaldi, MS ;
Moretti, A ;
Miccoli, P ;
Iacconi, P ;
Magagna, A ;
Salvetti, A .
JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1998, 21 (06) :365-371
[5]   Incidentalomas - A disease of modern technology [J].
Chidiac, RM ;
Aron, DC .
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 1997, 26 (01) :233-+
[6]   The incidental adrenal mass [J].
Cook, DM ;
Loriaux, DL .
AMERICAN JOURNAL OF MEDICINE, 1996, 101 (01) :88-94
[7]   PRECLINICAL CUSHINGS-SYNDROME - REPORT OF 3 CASES AND LITERATURE-REVIEW [J].
FERNANDEZREAL, JM ;
RICARTENGEL, W ;
SIMO, R .
HORMONE RESEARCH, 1994, 41 (5-6) :230-235
[8]   REDUCED SERUM LEVELS OF DEHYDROEPIANDROSTERONE-SULFATE IN ADRENAL INCIDENTALOMAS - A MARKER OF ADRENOCORTICAL TUMOR [J].
FLECCHIA, D ;
MAZZA, E ;
CARLINI, M ;
BLATTO, A ;
OLIVIERI, F ;
SERRA, G ;
CAMANNI, F ;
MESSINA, M .
CLINICAL ENDOCRINOLOGY, 1995, 42 (02) :129-134
[9]  
GLAZER HS, 1982, AM J ROENTGENOL, V139, P81, DOI 10.2214/ajr.139.1.81
[10]   EDITORIAL - A-I-D-S - THE NEW ENDOCRINE EPIDEMIC [J].
GRIFFING, GT .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 1994, 79 (06) :1530-1531